Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia

Medical Principles and Practice

Volumn 16, Issue 2, 2007, Pages 100-106

  Kaya, Emin ^a   Erkurt, Mehmet Ali ^a   Aydogdu, Ismet ^a   Kuku, Irfan ^a   Ozhan, Onur ^a   Oner, Ramazan Ilyas ^a   Ulutas, Ozkan ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Corticosteroid; Idiopathic thrombocytopenic purpura; Splenectomy

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; GLUCOSE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RHESUS D ANTIBODY; STEROID;

ACNE; ADULT; AGE DISTRIBUTION; APPETITE; ARTICLE; BLEEDING; DEEP VEIN THROMBOSIS; DISEASE FREE SURVIVAL; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MOON FACE; MYALGIA; NAUSEA; PSYCHOSIS; REMISSION; SEX RATIO; SIDE EFFECT; SPLENECTOMY; STATISTICAL SIGNIFICANCE; STRIA; TREATMENT OUTCOME; TURKEY (REPUBLIC); WEAKNESS; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; SPLENECTOMY; STEROIDS; TREATMENT OUTCOME; TURKEY;

EID: 33847068211     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098360     Document Type: Article

References (28)

1. The American Society of Hematology ITP Practice Guideline Panel: Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. Ann Intern Med 1997;126:319-326.
2. Woods VL Jr, Kurata Y, Montgomery RR, Tani P, Mason D, Oh EH, McMillan R: Autoantibodies against platelet glycoprotein Ib and IIb/IIIa complex in patients with chronic immune thrombocytopenic purpura. Blood 1984;64:156-160.
3. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ: Mechanism of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 1987;80:33-40.
4. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, Mc-Millan R, Okerbloom JA, Regan DH, Warrier I: Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
5. Frederiksen H, Schmidt K: The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999;94:909-913.
6. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, Oliva F, Sciarra A, Perrotti AP, Adomo G, Amadori S, Papa G: Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 1995;98:436-442.
7. Mazzucconi MG, Arista MC, Peraino M, Chistolini A, Felici C, Francavilla V, Macale E, Conti L, Gandolfo GM: Long-term followup of autoimmune thrombocytopenic purpura (ATP) patients submitted to splenectomy. Eur J Haematol 1999;62:219-222.
8. Karpatkin S: Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 1997;349:1531-1536.
9. Pamuk GE, Pamuk ON, Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N: Overview of 321 patients with idiopathic thrombocytopenic purpura: retrospective analysis of the clinical features and response to therapy. Ann Hematol 2002;81:436-440.
10. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A: Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001;97:2549-2554.
11. Vianelli N, Valdre L, Fiacchini M, de Vivo A, Gugliotta L, Catani L, Lemoli RM, Poli M, Tura S: Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients. Haematologica 2001;86:504-509.
12. Guthrie TH Jr, Brannan DP, Prisant LM: Idiopathic thrombocytopenic purpura in the older adult patient. Am J Med Sci 1988;296:17-21.
13. Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, Shapiro S: Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993;82:2714-2718.
14. Leung AY, Chim CS, Kwong YL, Lie AK, Au WY, Liang R: Clinicopathologic and prognostic features of chronic idiopathic thrombocytopenic purpura in adult Chinese patients: an analysis of 220 cases. Ann Hematol 2001;80:384-386.
15. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T: High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991;77:31-33.
16. Altintop L, Albayrak D: Oral high-dose methylprednisolone and intravenous immunoglobulin treatments in adult chronic idiopathic thrombocytopenic purpura. Am J Hematol 1997;56:191-192.
17. Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tuglular T, Tanriverdi S, Karti S, Bayik M, Akoglu T: Efficacy of high-dose methylprednisolone as first-line therapy in adult patients with idiopathic thrombocytopenic purpura. Br J Haematol 1998;103:1061-1063.
18. Den Ottolander GJ, Gratama JW, de Koning J, Brand A: Long-term follow-up study of 168 patients with immune thrombocytopenia: implications for therapy. Scand J Hematol 1984;32:101-110.
19. Shashaty GG, Rath CE: Idiopathic thrombocytopenic purpura in the elderly. Am J Med Sci 1978;276:263-267.
20. George JN, el-Harake MA, Raskob GE: Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1994;331:1207-1211.
21. Andersen JC: Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 1994;330:1560-1564.
22. Godeau B, Lesage S, Divine M, Wirquin V, Farcet JP, Bierling P: Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin. Blood 1993;82:1415-1421.
23. Kumar S, Diehn FE, Gertz MA, Tefferi A: Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol 2002;81:312-319.
24. Cooper N, Woloski BM, Fodero EM, Novoa M, Leber M, Beer JH, Bussel JB: Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Blood 2002;99:1922-1927.
25. Makris M, Greaves M, Winfield DA, Preston EE, Lilleyman JS: Long-term management after splenectomy: lifelong penicillin unproved in trials. BMJ 1994;308:131-132.
26. Ismet A, Irfan K, Emin K, Ali EM, Ramazan U, Mustafa B, Onur O: Splenectomy results in patients with idiopathic thrombocytopenic purpura: 10 years of experience in Turgut Ozal Medical Center. Clin Lab Haematol 2004;26:211-214.
27. Andres E, Zimmer J, Noel E, Kattenbach G, Koumarianou A, Maloisel F: Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of influence of age on the response to corticosteroids, splenectomy and danazol. Drugs Aging 2003;20:841-846.
28. Fabris F, Tassan T, Ramon R, Carraro G, Randi ML, Luzzatto G, Moschino P, Girolami A: Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura. Br J Haematol 2001;112:637-640.